Jan 10, 2019 - Big pharma CEOs hint at spur in M&A activity in 2019 at the 37th J.P. Morgan Healthcare Conference.
Jan 09, 2019 - After a dearth of purchase transactions across the industry, M&A has returned in a big way early in 2019 to the biotech space.Both Celgene and Loxo Oncology have been bought out for healthy premiums e
Jan 08, 2019 - Following two blockbuster merger and acquisition deals, a rise in M&A activity in the pharma space is likely led by consolidation in the cancer space.
Jan 07, 2019 - Innoviva is trading in a long-term, sustained, uptrend.The company reported strong EPS and revenue growth last quarter.Dividend reinstatement would bring back income investors.
Jan 07, 2019 - Jim Cramer says leading drugmakers are innovating more than ever before and many of their stocks are worth owning.
Jan 07, 2019 - In an interview with CNBC's Jim Cramer, GlaxoSmithKline (GSK +0.7%) CEO Emma Walmsley says there are "tremendous opportunities" to improve operating performance, adding that the company will g
Jan 07, 2019 - After announcing two major deals last month, GlaxoSmithKline CEO Emma Walmsley is still looking for more chances to transform Britain's largest drugmaker.
Jan 04, 2019 - Merck (MRK) exercises option to in-license an insulin sensitizer from NGM Biopharmaceuticals for NASH and type II diabetes. Its key drug Keytruda snaps up five new label expansion nods in Japan.
Jan 02, 2019 - Top Research Reports for Facebook, Wells Fargo & AT&T
Dec 31, 2018 - Novartis (NVS) gets a boost from strong performance of new drugs. Strategic acquisitions to foray into promising areas has also boosted investor sentiment.